Surmodics Stock Price. Everything You Need To Know About The Surmodics Stock!
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 447 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment manufactures performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilizers, substrates, surface coatings and antigens.
Surmodics Stock Price. Everything You Need To Know About The Surmodics Stock! performance
- Employees 447
- Company HQ Eden Prairie
- Website https://www.surmodics.com/
- SRDX Asset Type Common Stock
- SRDX Market Capitalization 372.6M
- Earnings Per Share 0.39
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 4.358
Investing in Surmodics stock from Malaysia, Thailand, Indonesia, and Vietnam can be a lucrative opportunity for retail investors looking to diversify their portfolios in the US market. Surmodics is a medical technology company that develops innovative products and solutions for the healthcare industry. With its strong focus on research and development, Surmodics has established itself as a leader in drug delivery, interventional medicine, and in vitro diagnostics. To invest in Surmodics stock, retail investors from Malaysia, Thailand, Indonesia, and Vietnam can leverage the user-friendly investment platform offered by Zorion. Zorion provides a seamless investment experience, allowing users to easily buy and sell real US stocks, including Surmodics. Moreover, Zorion offers valuable investment insights and recommendations, ensuring that investors from these countries can make informed decisions. In addition to the investment platform, Zorion provides retail investors from Malaysia, Thailand, Indonesia, and Vietnam with access to a wide range of educational materials and resources. These materials are designed to enhance investors’ knowledge and understanding of the stock market, helping them navigate the complexities of investing in Surmodics and other US stocks. Investing in Surmodics stock through Zorion is not only convenient but also offers an opportunity for retail investors to participate in the growth of an innovative medical technology company. Take advantage of Zorion’s investment platform and educational resources to unlock the potential of Surmodics stock from Malaysia, Thailand, Indonesia, and Vietnam. Start investing with Zorion today and make informed investment decisions that align with your financial goals.
